CN1144488A - 新型呼吸道病毒性疾病治疗药物 - Google Patents
新型呼吸道病毒性疾病治疗药物 Download PDFInfo
- Publication number
- CN1144488A CN1144488A CN95192216A CN95192216A CN1144488A CN 1144488 A CN1144488 A CN 1144488A CN 95192216 A CN95192216 A CN 95192216A CN 95192216 A CN95192216 A CN 95192216A CN 1144488 A CN1144488 A CN 1144488A
- Authority
- CN
- China
- Prior art keywords
- virus
- viral disease
- alp
- clara
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5223794 | 1994-03-23 | ||
JP52237/94 | 1994-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1144488A true CN1144488A (zh) | 1997-03-05 |
Family
ID=12909121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95192216A Pending CN1144488A (zh) | 1994-03-23 | 1995-03-20 | 新型呼吸道病毒性疾病治疗药物 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5900401A (cs) |
EP (1) | EP0804930A1 (cs) |
KR (1) | KR970701561A (cs) |
CN (1) | CN1144488A (cs) |
AU (1) | AU689559B2 (cs) |
BG (1) | BG100835A (cs) |
BR (1) | BR9507165A (cs) |
CA (1) | CA2186111A1 (cs) |
CZ (1) | CZ265896A3 (cs) |
FI (1) | FI963753A (cs) |
HU (1) | HUT75660A (cs) |
NZ (1) | NZ282488A (cs) |
PL (1) | PL316444A1 (cs) |
RO (1) | RO113431B1 (cs) |
SK (1) | SK119896A3 (cs) |
WO (1) | WO1995025539A1 (cs) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1021404E (pt) * | 1997-10-07 | 2003-04-30 | Boehringer Ingelheim Ca Ltd | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv |
AU9426198A (en) * | 1997-10-07 | 1999-04-27 | Boehringer Ingelheim (Canada) Ltd. | Azetidinone derivatives for the treatment of hcmv infections |
CA2301543C (en) * | 1997-10-07 | 2005-05-17 | Boehringer Ingelheim (Canada) Ltd. | Azetidinone derivatives for the treatment of hcmv infections |
US8679462B2 (en) * | 2002-04-11 | 2014-03-25 | Saeed Rezakhany | Methods of preventing respiratory infections |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0182906A1 (en) * | 1984-06-14 | 1986-06-04 | Cortech, Inc. | Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification |
JPS62501291A (ja) * | 1984-12-06 | 1987-05-21 | サイナ−ゲン バイオロジカルズ,インコ−ポレ−テツド | 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
US4760130A (en) * | 1984-12-06 | 1988-07-26 | Synergen Biologicals, Inc. | Serine protease inhibitors and methods for isolation of same |
IL77227A (en) * | 1984-12-06 | 1992-08-18 | Synergen Biolog Inc | Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
ATE92935T1 (de) * | 1984-12-06 | 1993-08-15 | Synergen Biolog Inc | Serinproteaseinhibitoren und isolierungsverfahren dazu. |
DE3600571A1 (de) * | 1986-01-10 | 1987-08-06 | Gruenenthal Gmbh | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel |
US5290762A (en) * | 1986-12-24 | 1994-03-01 | John Lezdey | Treatment of inflammation |
CA1340877C (en) * | 1987-12-28 | 2000-01-18 | Takashi Sugiyama | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
DE3841873A1 (de) * | 1988-12-13 | 1990-06-21 | Gruenenthal Gmbh | Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen |
JP3961029B2 (ja) * | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
US5334141A (en) * | 1992-06-26 | 1994-08-02 | Medrad, Inc. | Extravasation detection system and apparatus |
PL307864A1 (en) * | 1992-09-09 | 1995-06-26 | Synergen Inc | Retroviral infection inhibition |
US5376633A (en) * | 1992-09-30 | 1994-12-27 | Lezdey; John | Method for deactivating viruses in blood component containers |
US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
-
1995
- 1995-03-20 AU AU19611/95A patent/AU689559B2/en not_active Ceased
- 1995-03-20 US US08/716,404 patent/US5900401A/en not_active Expired - Fee Related
- 1995-03-20 PL PL95316444A patent/PL316444A1/xx unknown
- 1995-03-20 SK SK1198-96A patent/SK119896A3/sk unknown
- 1995-03-20 CZ CZ962658A patent/CZ265896A3/cs unknown
- 1995-03-20 CA CA002186111A patent/CA2186111A1/en not_active Abandoned
- 1995-03-20 EP EP95912487A patent/EP0804930A1/en not_active Withdrawn
- 1995-03-20 KR KR1019960705232A patent/KR970701561A/ko not_active Application Discontinuation
- 1995-03-20 BR BR9507165A patent/BR9507165A/pt not_active Application Discontinuation
- 1995-03-20 RO RO96-01846A patent/RO113431B1/ro unknown
- 1995-03-20 NZ NZ282488A patent/NZ282488A/en unknown
- 1995-03-20 CN CN95192216A patent/CN1144488A/zh active Pending
- 1995-03-20 HU HU9602598A patent/HUT75660A/hu unknown
- 1995-03-20 WO PCT/JP1995/000513 patent/WO1995025539A1/ja not_active Application Discontinuation
-
1996
- 1996-09-10 BG BG100835A patent/BG100835A/xx unknown
- 1996-09-20 FI FI963753A patent/FI963753A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995025539A1 (fr) | 1995-09-28 |
US5900401A (en) | 1999-05-04 |
HUT75660A (en) | 1997-05-28 |
SK119896A3 (en) | 1997-04-09 |
EP0804930A1 (en) | 1997-11-05 |
FI963753A0 (fi) | 1996-09-20 |
NZ282488A (en) | 1999-09-29 |
CZ265896A3 (en) | 1997-06-11 |
CA2186111A1 (en) | 1995-09-28 |
AU1961195A (en) | 1995-10-09 |
HU9602598D0 (en) | 1996-11-28 |
PL316444A1 (en) | 1997-01-20 |
BR9507165A (pt) | 1997-09-09 |
AU689559B2 (en) | 1998-04-02 |
KR970701561A (ko) | 1997-04-12 |
FI963753A (fi) | 1996-09-20 |
BG100835A (en) | 1997-06-30 |
RO113431B1 (ro) | 1998-07-30 |
EP0804930A4 (cs) | 1997-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7116823B2 (ja) | 新規なトリプシンアイソフォームおよびそれらの使用 | |
US6406698B1 (en) | Pharmaceutical composition comprising serum amyloid P component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components | |
CN102924562B (zh) | 一种人凝血因子ⅷ的干热处理稳定剂及其用途 | |
CN115996741A (zh) | 用于治疗急性呼吸窘迫综合征及病毒感染的cxcr4抑制剂 | |
CN111012736A (zh) | 一种阻断新型冠状病毒2019-nCov的无菌喷剂敷料的应用 | |
CN1144488A (zh) | 新型呼吸道病毒性疾病治疗药物 | |
Lopes et al. | Serine proteases in neutrophil extracellular traps exhibit anti-Respiratory Syncytial Virus activity | |
DK1427394T3 (da) | Fremgangsmåde til acceleration af restituering fra traume ved anvendelse af apoptose-imiterende syntetiske eller naturlige enheder | |
Müller et al. | Polyphosphate in antiviral protection: a polyanionic inorganic polymer in the fight against coronavirus SARS-CoV-2 infection | |
AU1695900A (en) | Antiviral peptides | |
EP1596851B1 (en) | The use of sodium 2-mercaptoethanesulfonate as antiviral agent | |
MXPA96004207A (en) | Novedous remedy for tractor pyrrato viral disease | |
US5106745A (en) | Broad spectrum virus inhibitor, UTI-β | |
Mahmood et al. | Angiotensin-Converting Enzyme 2: A new component of renin-angiotensin system (RAS) and a receptor for SARS-coronavirus-2 | |
Yves | SARS-CoV-2 Covid 19 Spikes Chemical Reaction with Climate Humidity | |
CN118267451A (zh) | 一种基于病毒阻断剂的鼻腔清洗喷雾剂及其用途 | |
CN104311644A (zh) | 多肽、提高多肽稳定性的方法、药物组合物以及多肽在制备药物中的用途 | |
CN116635051A (zh) | 抗严重急性呼吸综合征冠状病毒-2(SARS-CoV2)感染的作为ACE-2和S1亚基模拟物的肽及其缀合物 | |
HRP20000450A2 (en) | Prevention and/or treatment of allergic conditions | |
Copie et al. | Pharmaceutical composition comprising serum amyloid P component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Applicant after: Mitsubishi Pharmaceutical Co., Ltd. Applicant before: Tokyo Tanabe Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TOKYO TANABE CO., LTD. TO: MITSUBISHI TOKYO PHARMACEUTICAL CO., LTD. |
|
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |